2021

Hard To Say

Entrant

Havas Lynx

Category

Corporate Social Responsibility - Pro Bono (Free)

Client's Name

Childhood Tumor Trust

Country / Region

United Kingdom

Neurofibromatosis (NF1) is a genetic condition causing tumours to grow on nerve endings in children and young people. With 25,000 cases in the UK it’s more prevalent than Cystic Fibrosis, Duchenne Muscular Dystrophy, and Huntington’s Disease combined yet receives a fraction of attention.

By using unusual ways in which NF1 can sometimes be mispronounced ‘Hard to say’ aims to put NF1 in the spotlight to raise awareness and funds to help those living with the condition.